Kraig Biocraft Laboratories Inc (KBLB) Financiero

Kraig Biocraft Laboratories, Inc. operates as a biotechnology company, which focuses on the development and commercialization of spider silk. The company is headquartered in Ann Arbor, Michigan and currently employs 7 full-time employees. The company went IPO on 2008-02-29. The firm uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its primary fiber technology includes natural and engineered variants of spider silk produced from domesticated mulberry silkworms. The Company’s products use the characteristics of spider silk, specifically dragline silk from Nephila clavipes and variants thereof. Its applications include performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics and more. Its products include Monster Silk, Dragon Silk, and other products. Its recombinant spider silk fiber blends the silk proteins found in spider silk with the native silkworm silk proteins. The company also focuses on developing new recombinant silks and other protein-based fibers and materials.